ALX Oncology
ALXO
ALXO
93 hedge funds and large institutions have $688M invested in ALX Oncology in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
106% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 16
22% more funds holding
Funds holding: 76 → 93 (+17)
11.81% more ownership
Funds ownership: 80.88% → 92.69% (+12%)
Holders
93
Holding in Top 10
3
Calls
$4.14M
Puts
$1.29M
Top Buyers
| 1 | +$37.7M | |
| 2 | +$35.4M | |
| 3 | +$28M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$18.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.6M |
Top Sellers
| 1 | -$6M | |
| 2 | -$4.8M | |
| 3 | -$816K | |
| 4 |
Goldman Sachs
New York
|
-$601K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$453K |